We introduce an engineered nanobody whose affinity to green fluorescent protein (GFP) can be switched on and off with small molecules. By controlling the cellular localization of GFP fusion proteins, the engineered nanobody allows interrogation of their roles in basic biological processes, an approach that should be applicable to numerous previously described GFP fusions. We also outline how the binding affinities of other nanobodies can be controlled by small molecules.
and GFP LAMA N95 in greater detail (Fig. 1c-e and Supplementary  Fig. 2 ). All three GFP LAMAs retained a single-digit nanomolar affinity to GFP in the absence of ligands. For all three nanobodies, the affinity toward GFP was dramatically decreased in the presence of NADPH and TMP such that no binding to GFP could be detected for GFP LAMA F98 and GFP LAMA G97 (Fig. 1c-e and Supplementary  Fig. 3 ). For GFP LAMA F98 the presence of NADPH alone also affected the binding affinity to GFP, whereas the affinity of GFP LAMA G97 and GFP LAMA N95 was not affected by NADPH. The kinetics of dissociation of the complexes between GFP and GFP LAMA F98 or GFP LAMA G97 on addition of TMP were on the timescale of minutes: t 1/2 = 34 ± 1 s and t 1/2 = 5.6 ± 0.5 min for GFP LAMA F98 and GFP LAMA G97 , respectively ( Fig. 1f,g) . Subsequent removal of TMP by addition of wild-type DHFR resulted in reformation of the complexes within minutes (Fig. 1f,g) . The complex could then be dissociated again by addition of an excess amount of TMP ( Fig. 1f,g) . The dissociation kinetics of the complexes could also be tuned using DHFR inhibitors with different affinities to DHFR ( Supplementary Fig. 4) . These experiments underline that GFP LAMA F98 and GFP LAMA G97 can be repeatedly switched on and off through the addition of DHFR inhibitors.
To understand how the cpDHFR insertion into nanobodies allowed control of binding affinities, we solved the crystal structures of GFP LAMA F98 and GFP LAMA G97 in complex with NADPH and TMP. No big structural changes were seen in the nanobody domain of the two LAMAs relative to enhancer nanobody. Comparing these structures with the structure of enhancer nanobody bound to GFP suggests that folded cpDHFR sterically hampers binding to GFP ( Fig. 1h and Supplementary Fig. 5 ). The TMP-dependent control of the GFP LAMAs was abolished when GGS-linkers were inserted between cpDHFR and the nanobody ( Supplementary Fig. 6 ), indicating that the switching of nanobody affinity did not solely arise from insertion of the protein domain.
Given the large number of nanobodies that have been selected and characterized 14 , we attempted to expand the LAMA concept to other targets ( Supplementary Fig. 7a ). Nanobodies for G-associated kinase 15 did not allow for cpDHFR insertion into the tried positions ( Supplementary Fig. 7b,c) . A nanobody for lamina-associated polypeptide 1 (ref. 16 ) showed switching behavior on insertion of cpDHFR, with the addition of ligands increasing the affinity of the resulting LAMA ( Supplementary Fig. 7d,e ). A nanobody for the minimizer nanobody for GFP 12 showed greatly decreased affinities to its target on cpDHFR insertion, but responded to the addition of ligands ( Supplementary Fig. 7f,g) . A nanobody for the C-terminal region of the p24 HIV capsid protein (PDB ID 2XV6) could be readily converted into a LAMA on insertion of cpDHFR into the CDR3 Chemogenetic Control of Nanobodies Helen Farrants 1,2 , Miroslaw Tarnawski 3 , Thorsten G. Müller 4 , Shotaro Otsuka 5,6 , Julien Hiblot 1 , Birgit Koch 1 , Moritz Kueblbeck 5 , Hans-Georg Kräusslich 4 , Jan Ellenberg 5 and Kai Johnsson 1,2 ✉ loop ( Fig. 1i and Supplementary Fig. 8 ). The p24 LAMA S98 showed low nanomolar affinity for p24 HIV capsid protein when no ligands were present. Neither TMP nor NADPH alone could decrease the affinity of p24 LAMA S98 for its target, but addition of both ligands reduced the affinity 70-fold ( Fig. 1j ). Finally, cpDHFR was inserted into several positions of NbALFA, a recently developed nanobody for the ALFA-tag 17 , an only 15-amino-acid-long peptide ( Fig. 1k and Supplementary Fig. 9 ). Insertion of cpDHFR close to binding residues in CDR2 allowed switching of the affinity of the resulting ALFA-tag LAMA R59 with either TMP or NADPH (Fig. 1l ). These examples highlight the transferability of the LAMA approach to other nanobodies and furthermore underline that the availability of structural information on the interaction of the nanobody with its target greatly facilitates the generation of LAMAs.
The binding of both the p24 LAMA and GFP LAMAs to their targets could be switched on and off through the addition of TMP in live cells ( Fig. 2 ). Intracellular NADPH concentration in live cells is estimated to be 3.1 ± 0.3 µM (ref. 18 ). We measured the affinity of the GFP LAMAs to NADPH to be in this range in the absence of TMP, but increase cooperatively 50-fold on the addition of TMP ( Supplementary  Fig. 10 ). The expression of the cytosolic p24 precursor polyprotein Gag in HIV transfected cells stably expressing an enhanced GFP-(EGFP-) p24 LAMA S98 fusion ( Fig. 2a ) resulted in sequestering of the LAMA in the cytosol (Fig. 2b) . However, the LAMA was released from the p24 domain of Gag by the addition of TMP within minutes, as demonstrated by diffusion of EGFP-p24 LAMA S98 into the nucleus ( Fig. 2b and Supplementary Fig. 11 ). Furthermore, fusing the GFP LAMAs to Ntom20 (ref. 19 ), Lyn 11 (ref. 20 ) and a nuclear localization sequence reversibly sequestered EGFP to the outer membrane of the mitochondria, to the inner leaflet of the plasma membrane, and to the nucleus, respectively ( Fig. 2c, Supplementary Fig. 12 and Supplementary Videos 1-4). The complete EGFP sequestration requires an excess of GFP LAMA and the kinetics of the TMP-dependent release and sequestering of EGFP to the outer mitochondrial membrane occurred on a timescale of minutes, and could be repeated over several cycles ( Fig. 2e,f and Supplementary Fig. 13 ). 
GFP
LAMAs can be used to control the localization of other family members of GFP-based proteins to which the enhancer nanobody binds; for example, yellow fluorescent protein and Shadow G 21 , a nonfluorescent version of GFP ( Supplementary Fig. 14) . The high affinity of GFP LAMAs for GFP also allows to mislocalize GFP fusion proteins that are part of larger protein complexes. For example, transient transfection of mito-GFP LAMA F98 into a genome-edited cell line expressing NUP62-monomeric EGFP (mEGFP) ( Fig. 2g and Supplementary Fig.  15a ), a component of the nuclear pore complex, resulted in sequestering of NUP62-mEGFP from the nuclear envelope to the mitochondria in the absence of TMP ( Fig. 2h and Supplementary Fig. 15b ). GFP LAMA F98 was expressed as a fusion to SNAP-tag 22 , which allowed its visualization in the transfected cells. On addition of TMP, NUP62-mEGFP localized to the nuclear membrane.
GFP fusion proteins are omnipresent in the life sciences and our GFP LAMAs offer a new way to probe the function of these proteins. To demonstrate the potential of GFP LAMAs for mechanistic studies, we used mito-GFP LAMA F98 to control the function of a GFP fusion of Mad2L1, an important component of the mitotic checkpoint complex ( Fig. 2i and Supplementary Fig. 16 ). Knock-down of Mad2L1 reduces mitotic duration and increases the percentage of polylobed nuclei 23 . A HeLa Kyoto cell line in which endogenous Mad2L1 has been genome edited and tagged with EGFP has been previously described and used to map the localizations of Mad2L1 during mitosis 24 . We stably expressed mito-GFP LAMA F98 in the Mad2L1-EGFP cell line, and observed how sequestering Mad2L1-EGFP to the mitochondria affected the outcome of cell division (Supplementary Fig. 17 and Supplementary Videos 5-8). We could not generate Mad2L1-EGFP cell lines stably expressing the enhancer nanobody only, presumably because the affinity of the nanobody could not be switched off during the selection process. In the absence of TMP, we observed an increase in the percentage of polylobed nuclei following mitotic events relative to cells not expressing mito-GFP LAMA F98 (85 ± 13% versus 10 ± 6%; Fig. 2j and Supplementary Fig. 18 ). Addition of TMP to cells expressing mito-GFP LAMA F98 reduced the levels to those not expressing mito-GFP LAMA F98 (10 ± 11%). Next, nocodazole, a small molecule that prevents attachment of microtubules to kinetochores, was added to activate the mitotic checkpoint complex. After treatment with nocodazole, cells in which Mad2L1-EGFP had been sequestered at the mitochondria were able to override mitotic arrest ( Fig. 2k ), similar to treatment with reversine, a known drug that overrides the mitotic checkpoint 25 ( Supplementary Fig 19) . Treatment with nocodazole and TMP lead to mitotic arrest, as expected ( Fig.  2k and Supplementary Fig 19) . These data show that the function of Mad2L1-EGFP in the mitotic checkpoint complex can be controlled through its TMP-dependent interaction with mito-GFP LAMA F98 .
In summary, LAMAs are a generally applicable chemogenetic tool to reversibly control the location and function of proteins, including the most commonly used class of fusion proteins (GFP). Nanobodies have been selected for a large variety of targets, all of which could serve as starting point for the generation of new LAMAs. As TMP is a clinically approved drug, the approach might also be applicable in vivo. Furthermore, the design principle introduced here should be applicable for the generation of other switchable proteins.
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Methods DNA plasmids and molecular cloning. Plasmids were generated using standard molecular biology techniques. All subcloned sequences were verified using Sanger sequencing, assisted by Geneious software (Biomatters). pCHIV is a noninfectious HIV-1 viral construct lacking long terminal repeats and the nef gene 26 . pCHIV env(stop) was described earlier 27 and contains a Klenow Polymerase fill in at the NdeI site to generate a frameshift within the env gene. mCherry was inserted between MA (matrix protein) and CA (capsid protein) of the gag polyprotein and was described earlier 28 . pWPI puro was obtained from O. Fackler 29 . psPAX2 was a gift from D. Trono (Addgene plasmid no. 12260) and pCMV-VSV-G was a gift from R. Weinberg (Addgene plasmid no. 8454).
Chemical reagents. TMP, pyrimethamine and methotrexate were purchased from Sigma Aldrich. Stock solutions of 50 mM TMP in DMSO were used for both in vitro and in cell analysis. NADPH was purchased from PanReac Biochem, and stocks made to 10 mM fresh in aqueous buffer and used at the indicated concentrations. Nocodazol and reversine were purchased from Selleckchem. DMSO stock solutions were made fresh before use. Fluorescent dyes for live-cell imaging were purchased from available suppliers, or were synthesized as previously described 30, 31 .
Protein purification. Proteins were expressed using a pET51b(+) (Novagen) in Escherichia coli BL21 (DE3) pLysS, in the presence of 100 µg ml −1 ampicillin in Luria-Bertani, shaking at 220 r.p.m. Cultures were grown at 37 °C until an optical density (OD 600 ) of 0.8 was reached, and then induced with 1 mM isopropyl β-thiogalacopyranoside. After overnight expression at 25 °C, cells were collected and lysed by sonication. The lysates were cleared by centrifugation and purified by immobilized metal affinity chromatography (IMAC) using Ni-NTA Resin (Thermo Fisher Scientific). For proteins used in time-resolved-fluorescence resonance energy transfer (TR-FRET assays, His-tag purification was followed by Strep-Tactin purifications (IBA Lifesciences), according to the manufacturer's protocol. TR-FRET assay. Constructs assayed by TR-FRET were expressed as SNAP-tag fusions and EGFP-fusions. SNAP-tag on the target proteins (4 µM) was labeled with an excess of SNAP-Lumi4-Tb (Cisbio) (6 µM) in 50 mM HEPES, 50 mM NaCl, pH 7.3, at room temperature for 4 h. Excess unlabeled dye was removed by centrifugal filter units (Amicon). Tb-labeled target protein (for a final concentration of 1-20 nM in assays) was diluted in 50 mM HEPES, 50 mM NaCl, 0.5 mg ml −1 BSA, 0.05% Triton-X 100 (v/v), pH 7.3, containing 100 µM NADPH and placed into 384well plates (Black, flat-bottom, Corning no. 3821). EGFP-fused proteins were diluted in 50 mM HEPES, 50 mM NaCl, 0.5 mg ml −1 BSA, 0.05% Triton-X 100 (v/v), in the presence of TMP (500 µM, final concentration) or DMSO and/or NADPH (100 µM, final concentration). EGFP-fused proteins were mixed in a 1:1 ratio in the plate with the Tb-labeled target and incubated at least 15 min at room temperature. The plate was then read by a Spark 20 M microplate reader (Tecan) in TR-FRET mode. The excitation wavelength was 320 nm (25 nm bandwidth). The emission wavelength for Tb was 480 nm (7.5 nm bandwidth), and the emission wavelength for EGFP was 520 nm (7.5 nm bandwidth) using a 510 dichroic mirror. Integration time was 400 µs and lag time 120 µs. The titration curves were fitted to the full equation of single site binding, accounting for the effect of nonspecific binding.
Kinetics of in vitro dissociation. wtGFP was mixed with an excess of LAMA (1:3 ratio) on ice for 10 min and passed over size-exclusion chromatography. The heterodimeric fraction was collected and diluted into 50 mM HEPES, 50 mM NaCl, 0.5 mg ml −1 BSA, 0.05% Triton-X 100 (v/v), pH 7.3, in 96-well black flat-bottomed plates to a final concentration of 200 nM, in the presence of 100 µM NADPH. TMP, pyrimethamine or methotrexate were diluted in DMSO to 100× the final assay concentration. Then, 1 µl of relevant drug solutions was added to the 96-well plate and fluorescence emission recorded over time on a Spark 20 M microplate reader (Tecan). Excitation wavelength was 470 nm (5 nm bandwidth). Emission wavelength was 535 nm (5 nm bandwidth). For reversible association eDHFR was diluted in 50 mM HEPES, 50 mM NaCl, 0.5 mg ml −1 BSA, 0.05% Triton-X 100 (v/v) and 1 µl added to the reaction mix in the 96-well plate. The curves were fitted with one-phase dissociation models to estimate the half time at these concentrations.
Protein crystallization. For X-ray crystallography, the LAMAs were subcloned into a vector carrying an N-terminal Hisx10-tag, followed by a tobacco etch virus (TEV) protease cleavage tag sequence. The production and IMAC purification of the TEV protease was performed as previously described 33 . The His-Tag was removed from the LAMAs by TEV protease cleavage at 30 °C overnight, at a ratio of 1:20 (TEV protease: LAMA (w:w)). The digested protein was purified using a reverse IMAC purification method using Ni-NTA resin, collecting the flowthrough. The protein was passed over a size-exclusion column and concentrated using centrifugal filter units (Amicon). The protein was flash-frozen and stored at −70 °C in 25 mM HEPES, 25 mM NaCl, pH 7.3. Purified protein was premixed with NADPH (10 eq) and TMP (10 eq) as solid powders in 300 µl volume. The solution was left on ice for 10 min before centrifugation (20,000g, 10 min, 4 °C) to remove any precipitation.
Crystallization was performed at 20 °C using the vapor-diffusion method. Crystals of GFP LAMA F98 :NADFPH:TMP complex with a rod morphology were grown by mixing equal volumes of protein solution at 25 mg ml X-ray diffraction data collection and structure determination. Single crystal X-ray diffraction data were collected at 100 K on the X10SA beamline at the SLS (PSI). All data were processed with XDS 34 . The structures were determined by molecular replacement using Phaser 35 and individual protein coordinates from PDB entries 5UII and 5H8D as search models for DHFR and nanobody, respectively. The final models were optimized in iterative cycles of manual rebuilding using Coot 36 , and refinement using Refmac5 (ref. 37 ) and phenix.refine 38 . Data collection and refinement statistics are summarized in Supplementary Table  1 , model quality was validated with MolProbity 39 as implemented in PHENIX. The omit maps for ligands were generated using the composite omit map tool in PHENIX 38 .
Atomic coordinates and structure factors have been deposited in the Protein Data Bank (PDB) under accession codes 6RUL ( GFP LAMA F98 ) and 6RUM ( GFP LAMA G97 ). Analysis was conducted using MacPyMOL 40 and Coot 36 .
Mammalian cell culture maintenance. Eukaryotic cells were obtained from American Type Culture Collection (ATCC), The Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, or from collaborators as indicated. No cell lines on the ICLAC list of commonly misidentified cells were used in this work. All cells were cultured in DMEM GlutaMax (Thermo Fisher Scientific) medium supplemented with 10% FBS, and penicillin and streptomycin as indicated, at 37 °C in a humidified incubator with 5% CO 2 . All cells were mycoplasma free.
Generation of p24 LAMA s98 cell lines. Lentiviral particles were generated by cotransfection of transfer plasmid pWPI EGFP-p24 LAMA S98 IRES puro, packaging construct psPAX2, envelope protein expression plasmid pCMV-VSVG and pAdvantage (Promega) in a ratio of 1.5: 1: 0.5: 0.2, into HEK293T (ATCC) cells using PEI (1:3 ratio of µg DNA: µl 1 mg ml −1 PEI). The medium was changed after 6 h and production of lentiviral particles was allowed to proceed for 48 h. The supernatant was filtered through 0.45 µm MCE filters and was directly added to HeLa TZM-bl cells (NIH AIDS Repository). After 2 d the cells were expanded and 1 µg ml −1 puromycin was added to select for stably transduced cells.
Genome editing. Nup62 in HeLa Kyoto cells was endogenously tagged with mEGFP at the C terminus by CRISPR-Cas9 nickases and its homozygous integration was validated as described previously 41, 42 . The guide RNA sequences for the genome editing are as follows: 5′TCGCTCAGTCAAAGGTGATC3′ and 5′CTGGGGCCCGCAGGTCCCTA3′.
Previously described genome-edited HeLa Kyoto Mad2L1-EGFP 24 were used in the generation of stable cell lines expressing LAMAs. HeLa Kyoto Mad2L1-EGFP cells were seeded 1 d before transfection with pcDNA3.0 vectors with Lipofectamin3000 (Thermo Fisher Scientific), in the presence of TMP (10-50 µM), following the manufacturer's instructions. Cells were seeded monoclonal densities and selected using 500-800 µg ml −1 geneticin (Thermo Fisher Scientific) and TMP (10-50 µM) for 2 weeks. Cells were then labeled with BG-SiR (500 nM) overnight, before sorting on a FACSMelody (BD biosciences) for LAMA expressing cells.
Live-cell imaging of LAMA in CHIV (replication-defective HIV-1) expressing cells.
HeLa TZM-bl cells were seeded in eight-well Lab-Tek (nunc) at 20,000 cells per well the day before transfection in complete medium with 100 U ml −1 penicillin 100 µg ml −1 streptomycin and incubated at 37 °C and 5% CO 2 . pCHIV env(stop) was transfected in a 1:1 ratio with pCHIV env(stop) gag-mCherry
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Nature Methods using Turbofect (1:2 ratio). The cells were incubated for 24 h, the medium was changed to imaging medium (FluoroBrite DMEM (Thermo Fisher Scientific), 10% FBS, 4 mM GlutaMAX (Gibco Life Technologies), 2 mM sodium pyruvate (Gibco Life Technologies), 20 mM HEPES pH 7.4, 100 U ml −1 penicillin 100 µg ml −1 streptomycin (PAN-Biotech)) and transferred to a Nikon Eclipse Ti2 (Nikon, Japan) inverted microscope equipped with an Andor confocal spinning disk unit (Yokogawa CSU-W1 Spinning Disk Unit, Andor, Oxford Instruments). Cells were imaged at 37 °C and 5% CO 2 using a ×100 oil-immersion objective (Nikon CFI Apochromat TIRF ×100 Oil, numerical aperture (NA) 1.49) and a dual electron-multiplying charge-coupled device camera setup (Andor iXon DU-888), simultaneously recording the EGFP (488/500-550 nm) and the mCherry channel (568/575-625 nm) with a pixel size of 0.13 µm. Three-dimensional stacks (0.5 µm, z-spacing) were recorded with a time interval of 3 min for 60-120 min at up to 32 randomly chosen positions using the Nikon Imaging Software Elements 5.02. After 4-12 frames, 50 µl of TMP containing imaging medium was added to a final concentration of 10 µM and imaging was continued. For presentation purposes, the movies were filtered in FIJIi/ImageJ 43 with a mean filter (kernel size, 0.25 × 0.25 µm) to reduce noise. For quantification of the raw data, the mean intensity of a region of interest (ROI) inside the nucleus was measured using the Multi Measure function of the ROI Manager. Camera background was subtracted and intensities where normalized to the highest intensity within the ROI during the timeseries to correct for different expression levels. Different experiments were temporally aligned to the time of TMP addition and data was pooled from three independent experiments. 41 were transfected with Lipofectamin2000 (Thermo Fisher Scientific) according to the manufacturer's protocol. After 24 h, cells were seeded on Ibidi 0.6 Luer I cell culture treated perfusion chambers at 24,000 cells per chamber. All perfusion experiments were performed in complete DMEM GlutMax medium without phenol red. After the cells were adherent, BG-SiR (500 nM) was added to the perfusion chamber and labeled overnight at 37 °C. The perfusion chamber was then attached to a syringe pump, with a 20 ml syringe, and mounted on a Leica DMi8 microscope (Leica Microsystems) equipped with a Leica TCS SP8 X scanhead, a SuperK white-light laser and an HC PL APO ×40/1.10 W motCORR CS2 objective, at 37 °C. TMP (10 µM) was perfused over the cells at a flow rate or 1.5 ml min −1 , and images acquired at a scanning speed of 400 Hz, pixel dwell time 600 ns, pixel size 0.09 µm, with a pinhole at 1 airy unit, with z-stacks of 2 over 12 µm, with image acquisition every 18.24 s. A white-light laser was used for excitation, collecting with Leica HyD detectors: EGFP (488/505-550 nm), SiR (633/650-750 nm). Image analysis was conducted in FIJI/ImageJ using the Time Series Analyzer (3.0), selecting an ROI in the nucleus and measuring the fluorescent intensity over time, with background subtraction of a region outside the cells. All values were normalized to the intensity in the nucleus 13 min after TMP perfusion. Different experiments were temporally aligned to the time of TMP addition and data was pooled from three independent experiments.
Perfusion of TMP over live cells. HeLa Kyoto cells
Live-cell imaging of Nup62-mEGFP. Live-cell imaging of HeLa Nup62-mEGFP cells was performed at 37 °C in CO 2 -independent medium without phenol red (Invitrogen) containing 20% FBS, 2 mM l-glutamine and 100 µg ml −1 penicillin and streptomycin, with either 10 µM of TMP or DMSO (0.1% (v/v)). Cells were seeded on eight-well Lab-Tek Chambered Coverglass (Thermo Fisher Scientific) at 10,000 cells per well. Cells were incubated with 10 µM BG-TMR for 30 min and the BG-TMR was washed away before imaging. Cells were then observed by confocal microscopy (LSM780, Carl Zeiss) using a ×63, 1.4 NA Plan-Apochromat objective (Carl Zeiss), recording the mEGFP (488/491-552 nm) and TMR (561/580-660 nm) channels with a xy resolution of 0.13 µm and the section thickness of 1.2 µm. Fluorescence images were filtered with a median filter (kernel size, 0.25 × 0.25 µm 2 ) for presentation purposes.
Automated microscopy and analysis. For continuous live-cell imaging of HeLa Kyoto Mad2L1-EGFP cells stably expressing LAMAs, cells were seeded in 96-well plates (Eppendorf), in the presence of TMP (50 µM) at 10,000 cells per well. After cells were adherent, SNAP-tag in the fusion proteins was labeled with BG-SiR (100 nM) overnight. The cells were then labeled with Hoechst 33342 (1 µg ml −1 ) in complete medium without phenol red in the presence or absence of TMP (50 µM) for 15 min, and washed three times with complete medium without phenol red in the presence or absence of TMP (50 µM). Cells were imaged in the presence of BG-SiR (100 nM), in the presence or absence of TMP (50 µM), and in the presence of additional mitotic drugs as indicated, nocodazole (330 nM) or reversine (5 µM). Automatic microscopy was conducted using Leica HCS A Matrix Screener software on a Leica DMi8 microscope (Leica Microsystems) equipped with a Leica TCS SP8 X scanhead, a SuperK white-light laser and an HC PL APO ×40/1.10 W motCORR CS2 objective, at 37 °C, 5% CO 2 , achieved by a temperature controllable incubator (Life Imaging Services). A white-light laser or 405 nm diode was used to excite the fluorophores, collecting with Leica HyD detectors: Hoechst (405/425-475 nm), SiR (633/650-750 nm). Image acquisition was conducted at a speed of 400 Hz, pixel dwell time 1.2 µs, pixel size 0.57 µm, with z-stacks of 1 over 10 µm. Image analysis was conducted in FIJI/ImageJ, with manual annotations of LAMA expressing cells followed from prometaphase to mitotic exit.
Fitting models for in vitro characterization. The full equation for single site binding, accounting for the effect of nonspecific binding was used to fit the wtGFP fluorescence emission assay and TR-FRET assay:
where y is the emission at 535 nm, F sb is the fraction of protein bound, F max and F min are the maximum and minimum emission values, x is the concentration of nanobody protein titrated into wtGFP or the Tb-labeled target, N is a parameter for nonspecific binding, L is the total concentration of wtGFP or Tb-labeled target (L = 1-20 nM) and K d is the calculated dissociation constant between the nanobody derivative and wtGFP or Tb-labeled target.
One-phase association and dissociation for kinetic measurements in vitro and in cellulo.
Time-series data of association were fit with a pseudo first-order exponential model, according to:
where y is the measured in tensity, y 0 is the intensity at time 0, NS is the minimal intensity measured at infinite time, k is the pseudo-first-order rate constant, t is the time and t 1/2 is the half time. Time-series data of dissociation were fit with a pseudo first-order exponential model, according to:
where y is the measured intensity, y 0 is the intensity at time 0, y max is the maximal intensity measured, k is the pseudo-first-order rate constant and t is the time.
ITC. Proteins were dialyzed using mini dialysis kits (GE Healthcare) containing NADPH (1 mM) and/or TMP (0.5 mM of DMSO) as indicated. The protein concentrations were measured by A 280 using a nanodrop (1 mm pathlength). The molar extinction coefficient was estimated using the Geneious software (Biomatters). A Microcal PEAQ-ITC microcalorimeter was used for the measurements. Protein concentration ranged from 10 to 40 µM in the cell, and a 10-fold excess in the syringe. Eight-or 13-injection programs were chosen depending on the expected affinity between the molecular entities.
Translocation of fluorescent proteins. HeLa Kyoto cells were seeded in 96well plates (Eppendorf) at 10,000 cells per well 24 h before transfection with Lipofectamin2000 (Thermo Fisher Scientific) according to the manufacturer's protocol. After 24 h, complete medium without phenol red was added to the cells. Cells were labeled with BG-SiR (500 nM) overnight, in the presence or absence of 10 µM TMP or DMSO (0.1% v/v), before being imaged by confocal microscopy using a Leica DMi8 microscope (Leica Microsystems) equipped with a Leica TCS SP8 X scanhead; a SuperK white-light laser, and an HC PL APO ×40/1.10 W motCORR CS2 objective, at 37 °C with 5% CO 2 , achieved by a temperature controllable incubator (Life Imaging Services). Image acquisition was conducted at a speed of 400 Hz, pixel dwell time of 600 ns, pixel size 0.06 µm, with z-stacks of 1 over 10 µm. A white-light laser was used for excitation, collecting with Leica HyD detectors: EGFP (488/505-550 nm), yellow fluorescent protein (514/525-573 nm), ShadowG-mScarlet (561/583-625 nm) and SiR (633/650-750 nm).
Genome-edited NUP62-EGFP. The probe sequences for Southern blotting are as follows. GC AG GT TC CA GG AG AC TC TG CA GG GG TG CC ATTCACATGAAACGCACAG  GCAAGCAAATGAAGTAGTGCTTGCATAGACATAGGGGTATGCGATGAAG  CAGCTTTTGTTTGATGAGACAGAGTAATAGACAAATGCAAATCGTGGTTT  GCTCCAGGAA3′; mEGFP: 5′C AC AT GA AG CA GC AC GA CT TC TT CA AG TC CG CC AT GC CC-GA AG GC TA CG TC CA GG AG CG CA CC AT CT TC TT CA AG GA CG AC GG CA AC-TA CA AG AC CC GC GC CG AG GT GA AG TT CG AG GG CG AC AC CC TG GT GA AC-CG CA TC GA GC TG AA GG GC AT CG AC TT CA AG GA GG AC GG CA AC AT CC TG-GG GC AC AA GC TG GA GT ACAACTACAACAGCCACAACGTCTATATCATGGC CGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAAC
Nup62-mEGFP: 5 ′A A C T T A G TG G C A C C A GA G T A A C T CT A G T C A G TT A C -A G T A AA A T C C A C TG T G T G T G GA A G G C A G AA G C T A G C GG T T G T A T CC C A -A G C A TC T T T T G T AT T T G T C T TT A T A C T T TG C T G A A T TC T C T G A A AT A C C T -A T TA C T G T A T GT T G C T T T TC T A A A T A AA T G T A T T GT G A A A C C AA A A C A G -C TG C T G T T A AT A T G G A T AA A T G T T A GG A G GA G A AA G C TG A G TA A A AA G A -
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Nature Methods ATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGA ACACCC3′. Fig. 1c -e,j,l were performed in triplicates in at least three independent experiments with similar results. The in vitro kinetics was measured in triplicates in three independent experiments with similar results. The mean ± s.d. is plotted for these experiments.
Statistical analysis. The titrations in
For live-cell imaging of LAMAs in Fig. 2b,d , representative images are shown from three independent experiments with similar results. For analyzing the kinetics of GFP LAMAs in live cells in Fig. 2e ,f, data was is plotted as the mean ± s.e.m. from three independent perfusions with N = 14 cells for GFP LAMA F98 and N = 9 cells for GFP LAMA G97 . In Fig. 2h , experiments were performed twice independently and the sequestering was reliably reproduced. For scoring nuclear morphology after mitosis in Fig. 2j , five time-lapse series from independent experiments were manually scored and the percentage of polylobed cells is plotted as the mean ± s.d. For scoring the time spent in mitosis in Fig. 2k , data from three independent time-lapse series were manually scored and potted as the median ± interquartile range. The total number of cells analyzed that underwent mitosis during time-lapse imaging was N = 63 for wash-out of TMP with DMSO and N = 19 for cells kept in TMP.
For details of statistical analysis in the Supplementary Figures, see respective  figure legends .
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
data availability
Plasmids encoding for LAMAs have been deposited on Addgene with accession codes 130704 to 130718 and 136618 to 136635. All requests for the Nup62-mEGFP genome-edited cell line should be directed to J.E. Structures of GFP LAMA F98 and GFP LAMA G97 have been deposited to the PDB with deposition codes 6RUL and 6RUM, respectively. The source data for Figs. 1c-g,j,l and 2e,f,j,k are provided with the paper online. Additional datasets that support the finding of this study are available from the corresponding author upon request.
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